Key result
This letter to the editor discusses a previously published study on the efficacy and safety of fibrinolytic therapy in patients with prosthetic valve thrombosis and high INR, presenting no new data.
A letter to the editor discussing the safety of fibrinolytic therapy in patients with prosthetic valve thrombosis and elevated INR.
To the Editor, We have recently read with great interest the article by Farzaneh et al.1 entitled “Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels.” The authors reported the study of efficacy and safety of fibrinolytic therapy at elevated international normalized ratio (INR) in patients with prosthetic valve thrombosis (PVT).1
No takes yet. Share an insight, caveat, or question.
Güner et al. (2020) conducted a letter in Prosthetic valve thrombosis with elevated international normalized ratio (INR). Fibrinolytic therapy was evaluated. This letter to the editor discusses a previously published study on the efficacy and safety of fibrinolytic therapy in patients with prosthetic valve thrombosis and high INR, presenting no new data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: